LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 332 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 2.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $411,051 | -21.5% | 6,860 | -5.6% | 0.00% | 0.0% |
| Q2 2023 | $523,735 | +2.9% | 7,264 | +5.0% | 0.00% | 0.0% |
| Q1 2023 | $509,036 | +19.5% | 6,920 | +8.5% | 0.00% | 0.0% |
| Q4 2022 | $425,850 | -15.7% | 6,375 | +8.8% | 0.00% | -20.0% |
| Q3 2022 | $505,000 | +107.8% | 5,861 | +115.8% | 0.01% | +150.0% |
| Q2 2022 | $243,000 | -89.2% | 2,716 | -88.5% | 0.00% | -87.5% |
| Q3 2020 | $2,255,000 | -14.5% | 23,655 | +0.4% | 0.02% | -20.0% |
| Q2 2020 | $2,636,000 | +57.6% | 23,563 | +2.4% | 0.02% | +17.6% |
| Q1 2020 | $1,673,000 | -38.3% | 23,009 | -11.6% | 0.02% | -15.0% |
| Q4 2019 | $2,713,000 | +26.4% | 26,015 | +20.7% | 0.02% | +17.6% |
| Q3 2019 | $2,146,000 | -21.6% | 21,562 | -10.1% | 0.02% | -22.7% |
| Q2 2019 | $2,736,000 | -17.9% | 23,972 | -9.6% | 0.02% | -18.5% |
| Q1 2019 | $3,334,000 | -22.2% | 26,519 | -16.0% | 0.03% | -25.0% |
| Q4 2018 | $4,284,000 | -41.0% | 31,569 | +19.4% | 0.04% | -23.4% |
| Q3 2018 | $7,258,000 | +52.5% | 26,442 | +15.1% | 0.05% | +46.9% |
| Q2 2018 | $4,758,000 | -19.1% | 22,967 | -35.5% | 0.03% | +128.6% |
| Q1 2018 | $5,880,000 | +13.8% | 35,613 | -5.6% | 0.01% | +16.7% |
| Q4 2017 | $5,166,000 | -3.3% | 37,728 | -3.9% | 0.01% | -7.7% |
| Q3 2017 | $5,342,000 | +17.3% | 39,243 | +4.6% | 0.01% | +8.3% |
| Q2 2017 | $4,556,000 | +14.4% | 37,531 | -0.2% | 0.01% | +9.1% |
| Q1 2017 | $3,982,000 | +6.2% | 37,604 | +1.9% | 0.01% | 0.0% |
| Q4 2016 | $3,751,000 | -41.4% | 36,914 | -41.2% | 0.01% | -45.0% |
| Q3 2016 | $6,405,000 | -18.6% | 62,762 | -4.9% | 0.02% | -20.0% |
| Q2 2016 | $7,869,000 | +1.8% | 65,974 | -8.6% | 0.02% | +4.2% |
| Q1 2016 | $7,728,000 | -24.2% | 72,163 | -23.3% | 0.02% | -20.0% |
| Q4 2015 | $10,198,000 | +22.3% | 94,060 | -3.4% | 0.03% | +15.4% |
| Q3 2015 | $8,341,000 | -29.8% | 97,393 | -17.3% | 0.03% | -10.3% |
| Q2 2015 | $11,883,000 | +41.9% | 117,778 | +8.4% | 0.03% | +45.0% |
| Q1 2015 | $8,377,000 | +44.2% | 108,642 | -0.5% | 0.02% | +33.3% |
| Q4 2014 | $5,810,000 | +16.2% | 109,187 | +2.6% | 0.02% | +25.0% |
| Q3 2014 | $5,002,000 | +23.9% | 106,428 | +64.2% | 0.01% | +20.0% |
| Q2 2014 | $4,036,000 | -20.3% | 64,800 | -14.0% | 0.01% | -28.6% |
| Q1 2014 | $5,067,000 | +12.1% | 75,328 | -12.4% | 0.01% | 0.0% |
| Q4 2013 | $4,522,000 | – | 85,976 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |